How will Brexit affect your pension prospects?

What should you do if you’re worried about your pension after leaving the EU?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Are you worried about the prospects for your pension now that the UK electorate has voted to leave the European Union? It’s entirely understandable if you are — but what should you do?

Well, funnily enough, I got an email from Hargreaves Lansdown, my SIPP provider, this week, and their first recommendation is to “remain calm and keep focused on your long-term plans” — and that’s absolutely right.

The immediate problem for people approaching retirement is that annuity rates have already fallen, some by around 2%. An annuity is a product that many people buy with some or all of their pension pot, and which pays a regular income — but I see annuities as very poor investments.

Firstly, returns are low. And secondly, you sacrifice your entire cash on day one. So, if you die the next day, there won’t be a penny for you to leave to your children. With gilt yields being low, and expected to remain low, today’s lower annuity rates also seem likely to stay that way for some time.

State pensions could now be under threat, too. Current rules mean that, under the so-called “triple lock” guarantee, they would rise every year by inflation, average earnings, or 2.5%, whichever is highest. But David Cameron has warned that this protection could be lost should Brexit lead to an economic downturn.

Profit from uncertainty

For those investing in shares for their retirement, the outlook is also uncertain — but still pretty rosy, at least in the long term. Most economists believe an exit from the EU will damage the UK’s growth, and lower GDP over the next few years would surely translate into a poorer return from shares than we’d otherwise get.

But on the other hand, most of our top FTSE 100 companies operate worldwide and should still have a very healthy long-term future. And the immediate post-referendum rout, coupled with any sustained weakness in share prices over the coming months, should provide those with a longer-term pensions outlook with some nice buying opportunities.

I recently noted that top fund manager Neil Woodford reckons that the Brexit vote “is not as negative a development as the market’s initial reaction appears to imply“.

Furthermore, he strongly urges us to

look through this period of uncertainty and focus on the long-term opportunity which, in our view, continues to remain attractive“.

So if you have some cash that you can use to boost your pension provisions, now could be a great time for a few top-ups. In particular, I’m thinking about solid dividend-paying shares — getting in while share prices are low can lock in higher dividend yields for life, as the only yield that matters is the yield on your original purchase price. So which shares should you be considering?

Global outlook

The most obvious are truly global companies, which are relatively immune to local and regional politics. I see BP and Royal Dutch Shell, with predicted dividend yields of 6.6% and 6.5% respectively, as key contenders in the EU-safe investment stakes. And its no surprise that shares in both have gained since the vote — it’s not long ago that we were seeing yields in excess of 7%.

The big pharmaceuticals should have great pension potential, too, with GlaxoSmithKline on a forecast yield of 5.3% and AstraZeneca on 4.5% (after both shares have been boosted by the recent flight to safety). Not the biggest yields, but very attractive, and at a time when both companies are set to rebound from their patent-expiry problems of recent years.

But if you want to take a bit more risk and try to benefit from the immediate post-event fallout, Lloyds Banking Group shares are now on a predicted yield of 8%, housebuilder Taylor Wimpey is offering 8.3%, and even the yield at super-conservative insurer Prudential is up to 3.4% — if you think they’re oversold, you now have your chance to profit.

Facing plenty of uncertainty, the worst mistake you can make now is to panic and run away from managing your own investments — instead, you should use the lemon you’ve been handed to make lemonade!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft owns shares of Lloyds Banking Group. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca, BP, Hargreaves Lansdown, and Royal Dutch Shell. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in January [PREMIUM PICKS]

Highlighting some of our past recommendations we think are of particular interest today, due to a combination of business performance…

Read more »

artificial intelligence investing algorithms
Investing Articles

I asked Google AI for the best UK stocks for me to buy for 2025. Here are 5 names it gave me

Dr James Fox turned to artificial intelligence to explore the best UK stocks to buy in 2025. Here’s what Google’s…

Read more »

Investing Articles

2 no-brainer growth shares to consider in 2025!

These FTSE 100 and FTSE 250 growth shares delivered impressive share price gains in 2024. I think they should continue…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How much would an investor need in an ISA for £800 in monthly passive income?

Generating a healthy dollop of monthly passive income need not remain a pipe dream. Paul Summers has whipped out his…

Read more »

Investing Articles

Has Tesla stock had its best days already?

Tesla stock has jumped around 70% in just a couple of months. Our writer likes the business -- but he's…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

In 3 steps, a new investor could start buying shares with just £500

Christopher Ruane outlines a trio of moves he thinks someone with a spare few hundred pounds could consider if they…

Read more »

Investing Articles

Up 513%! Can the Rolls-Royce share price  keep soaring in 2025?

Our writer sees reasons why the Rolls-Royce share price could go either way this year. Here's why he has no…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

£10,000 invested in Nvidia stock in 2020 would now be worth £244k! Here’s what could be next

Nvidia stock’s dominated the ‘picks and shovels’ market for artificial intelligence, but Dr James Fox believes it could be primed…

Read more »